FIRMM-pix, a brain magnetic resonance imaging (MRI) software module recently launched at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly employs visual biofeedback and gamification that coaches patients to stay still during brain MRI exams.
Is gamification the answer to reducing motion distortion during brain magnetic resonance imaging (MRI) exams?
Turing Medical Technologies has launched FIRMM-pix, a brain MRI software module, which utilizes gamification and visual biofeedback to ease patient anxiety and reduce head movement during exams.
FIRMM-pix, which was recently showcased at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly utilizes licensed movie content and a comforting guide dog in one game called Puppy Dreams to help calm patients and inform them about movements during brain MRI exams.
“Motion-induced image degradation remains a significant weakness of brain MRI, making it difficult to acquire a scan quickly. With a solution like FIRMMpix, we have the potential to conduct high-fidelity scans without compromising important data and without the need for anesthesia. Moreover, its patient-centric design fosters active participation, making the scanning process more comfortable and inclusive for patients,” noted Lawrence Tanenbaum, M.D., vice president, chief technology officer and director of advanced imaging at RadNet.
Turing Medical Technologies said FIRMM-pix is a complement to the existing FIRMM brain MRI software, which helps monitor head motion during exams and provides real-time feedback to technologists. Use of the FIRMM software can lead to a 25 percent reduction of unnecessary repeat brain MRI scans and greater than $115,000 in annual cost-savings per MRI scanner, according to the company.
(Editor’s note: For related content, see “Can Abbreviated MRI Have an Impact in Neuroimaging?” and “New MRI Study Examines Impact of Disparities with Childhood Adversity Exposure on Brain Development.”)
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the